miércoles, 21 de febrero de 2018

Health News and Information - News Medical - Pulmonology - Feb 21, 2018 Edition

Health News and Information - News Medical



 
 February 21, 2018 
 Pulmonology 
 The latest pulmonology news from News Medical 
 Women using short-acting asthma relievers take longer to become pregnant, study showsWomen using short-acting asthma relievers take longer to become pregnant, study shows
 
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to international research led by the University of Adelaide.
 
   Early childhood immune signature predicts risk of developing asthma later onEarly childhood immune signature predicts risk of developing asthma later on
 
Asthma is a chronic inflammatory disease driven by the interplay of genetics, environmental factors and a diverse cast of immune cells.
 
   Accurate Breath Analysis with Breath Holding and End-Tidal SamplesAccurate Breath Analysis with Breath Holding and End-Tidal Samples
 
This article explains why a 15 second breath hold is needed to investigate carbon monoxide (CO), methane (CH4), and hydrogen (H2) from breath analysis.
 
 COPD and Sleep Apnea
 
COPD and Sleep ApneaThis article describes a condition called overlap syndrome, where patients exhibit symptoms of both COPD and sleep apnea.
 
 
 Study identifies risk factors for sleep apnea in pregnant woman
 
Study identifies risk factors for sleep apnea in pregnant womanSnoring, older age and obesity may increase a pregnant woman's risk for sleep apnea--or interrupted breathing during sleep--according to researchers funded by the National Institutes of Health.
 
 
 LUNGevity Foundation launches initiative to promote stronger adherence to lung cancer screening
 
LUNGevity Foundation launches initiative to promote stronger adherence to lung cancer screeningLUNGevity Foundation announced the launch of Project ACTS – Increasing Adherence to CT Screening for lung cancer – a multi-stakeholder project funded by a grant from Bristol-Myers Squibb Foundation through their Bridging Cancer Care initiative.
 
 
 Computerized tissue-imaging may help predict early recurrence of lung cancer
 
Computerized tissue-imaging may help predict early recurrence of lung cancerCase Western Reserve and Cleveland Clinic are leading development of a computerized tissue-imaging program that could soon help identify which lung cancer patients are likely to face an earlier recurrence of the disease.
 
 
 Common asthma drug retards development of aortic aneurysm in mice, study shows
 
Common asthma drug retards development of aortic aneurysm in mice, study showsAortic aneurysm - the dilation of the aorta - is a serious condition that lacks effective drug treatment. Researchers at Karolinska Institutet in Sweden report in the journal PNAS, however, that a common asthma drug can retard the development of aortic aneurysm in mice.
 
 
 Cleaner shipping fuels will result in reduction of childhood asthma, study finds
 
Cleaner shipping fuels will result in reduction of childhood asthma, study findsMarine shipping fuels will get a whole lot cleaner in 2020 when a regulation by the International Maritime Organization requires fuels to contain 80-86 percent less sulfur.
 
 
 Researchers use molecular simulations to understand lung cancer drug resistance
 
Researchers use molecular simulations to understand lung cancer drug resistanceScientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer.
 
 
 Vapors could elevate pneumonia risk, study states
 
Vapors could elevate pneumonia risk, study statesA new study suggests inhaling vapor from e-cigarettes could cause pneumonia-causing bacteria to attach to the cells that line airways.
 
 
 FDA approves first treatment to reduce risk of NSCLC progression
 
FDA approves first treatment to reduce risk of NSCLC progressionThe U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
 
 
 COPD Risk Factors
 
COPD Risk FactorsWhile there is no cure, early diagnosis can significantly minimize lung damage.
 
 
 Chronic Obstructive Pulmonary Disease Treatment
 
Chronic Obstructive Pulmonary Disease TreatmentThis article describes Chronic Obstructive Pulmonary Disease, including associated conditions, causes and methods of treating the disease.
 
 
 New tool measures cell strength 100 times faster than current technologies
 
New tool measures cell strength 100 times faster than current technologiesEngineers, doctors and scientists at UCLA and Rutgers University have developed a tool that measures the physical strength of individual cells 100 times faster than current technologies.
 
 
 Chinese researchers report first clinical trial based on autologous lung stem cell transplantation
 
Chinese researchers report first clinical trial based on autologous lung stem cell transplantationA research team from Tongji University in China have made a breakthrough in human lung regeneration technology. For the first time, researchers have regenerated patients' damaged lungs using autologous lung stem cell transplantation in a pilot clinical trial.
 
 
 Opioid users have increased risk of invasive pneumococcal diseases
 
Opioid users have increased risk of invasive pneumococcal diseasesOpioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.
 

No hay comentarios:

Publicar un comentario